Contact
searchSearch
HMP Global

News

News
Steroid Injection Recalled
06/27/2024
More than 70 000 vials of dexamethasone sodium phosphate injection are under recall for an impurity.
More than 70 000 vials of dexamethasone sodium phosphate injection are under recall for an impurity.
More than 70 000 vials of...
06/27/2024
Pharmacy Learning Network
News
Blood Thinner Recalled
06/27/2024
Eugia US is recalling 15 500 single-dose vials of eptifibatide injection.
Eugia US is recalling 15 500 single-dose vials of eptifibatide injection.
Eugia US is recalling 15 500...
06/27/2024
Pharmacy Learning Network
News
Corticosteroid Injection Recalled
06/19/2024
Pacira Pharmaceuticals Inc. is recalling 43 768 kits of Zilretta (triamcinolone acetonide extended-release injectable suspension) for failing stability testing.
Pacira Pharmaceuticals Inc. is recalling 43 768 kits of Zilretta (triamcinolone acetonide extended-release injectable suspension) for failing stability testing.
Pacira Pharmaceuticals Inc. is...
06/19/2024
Pharmacy Learning Network
News
Ophthalmic Emulsion Recalled
06/19/2024
Imprimis NJOF is recalling 136,005 units of Klarity-C Drops (cyclosporine 0.1%) preservative-free ophthalmic emulsion for topical use because of sterility concerns.
Imprimis NJOF is recalling 136,005 units of Klarity-C Drops (cyclosporine 0.1%) preservative-free ophthalmic emulsion for topical use because of sterility concerns.
Imprimis NJOF is recalling...
06/19/2024
Pharmacy Learning Network
News
Ophthalmic Suspension Recalled for Sterility Concerns
06/19/2024
A lack of assurance of sterility has prompted Imprimis NJOF to voluntarily recall 4280 boxes of compounded prednisolone acetate 1%, moxifloxacin 0.5%, and bromfenac 0.075% ophthalmic suspension.
A lack of assurance of sterility has prompted Imprimis NJOF to voluntarily recall 4280 boxes of compounded prednisolone acetate 1%, moxifloxacin 0.5%, and bromfenac 0.075% ophthalmic suspension.
A lack of assurance of sterility...
06/19/2024
Pharmacy Learning Network
News
HIV Medication Recalled
06/13/2024
GlaxoSmithKline LLC is recalling 463 cartons of Tivicay PD because the product box lists incorrect expiration information.
GlaxoSmithKline LLC is recalling 463 cartons of Tivicay PD because the product box lists incorrect expiration information.
GlaxoSmithKline LLC is recalling...
06/13/2024
Pharmacy Learning Network
News
Mislabeled Antibiotics Recalled
06/13/2024
Bryant Ranch Prepack Inc. is recalling 456 bottles of cephalexin for oral suspension due to various labeling errors.
Bryant Ranch Prepack Inc. is recalling 456 bottles of cephalexin for oral suspension due to various labeling errors.
Bryant Ranch Prepack Inc. is...
06/13/2024
Pharmacy Learning Network
News
Officials Will Continue to Assess Guillain-Barré Syndrome Risk After RSV Vaccine
06/12/2024
Consistent with prelicensure clinical trials, nearly a year of respiratory syncytial virus (RSV) vaccine use in US older adults showed higher-than-expected rates of Guillain-Barré syndrome after RSV vaccination compared with after COVID-19...
Consistent with prelicensure clinical trials, nearly a year of respiratory syncytial virus (RSV) vaccine use in US older adults showed higher-than-expected rates of Guillain-Barré syndrome after RSV vaccination compared with after COVID-19...
Consistent with prelicensure...
06/12/2024
Pharmacy Learning Network
News
Migraine Tablets Pulled
06/12/2024
Glenmark Pharmaceuticals Inc. USA is recalling 10 lots of rizatriptan benzoate tablets and rizatriptan benzoate orally disintegrating tablets because of an N-nitroso desmethyl rizatriptan impurity.
Glenmark Pharmaceuticals Inc. USA is recalling 10 lots of rizatriptan benzoate tablets and rizatriptan benzoate orally disintegrating tablets because of an N-nitroso desmethyl rizatriptan impurity.
Glenmark Pharmaceuticals Inc....
06/12/2024
Pharmacy Learning Network
News
Intraocular Injection Recalled
06/06/2024
Imprimis NJOF is recalling 14,180 vials of epinephrine-lidocaine for intraocular injection due to a lack of assurance of sterility.
Imprimis NJOF is recalling 14,180 vials of epinephrine-lidocaine for intraocular injection due to a lack of assurance of sterility.
Imprimis NJOF is recalling...
06/06/2024
Pharmacy Learning Network

Stay Informed & Sign Up Today

Pharmacy Learning Network Newsletter

Video Insights

Videos
David Rubin, MD, on JAK Inhibitors: Small But Mighty
11/22/2023
Dr Rubin reviews his presentation from the Advances in Inflammatory Bowel Disease regional meeting on the latest information on the safety and efficacy of Janus kinase inhibitors for the treatment of inflammatory bowel disease.
Dr Rubin reviews his presentation from the Advances in Inflammatory Bowel Disease regional meeting on the latest information on the safety and efficacy of Janus kinase inhibitors for the treatment of inflammatory bowel disease.
Dr Rubin reviews his...
11/22/2023
Pharmacy Learning Network
Videos
Advantages and Drawbacks of Lecanemab in Alzheimer Disease Treatment
11/10/2023
Dr Shulz discusses the FDA-approved lecanemab for the treatment of AD.
Dr Shulz discusses the FDA-approved lecanemab for the treatment of AD.
Dr Shulz discusses the...
11/10/2023
Pharmacy Learning Network
Videos
Immunosuppressants or Immunomodulators? Biologic Agents for Psoriasis
10/27/2023
In this exclusive interview, Dr Ronald Vender goes over the highly effective targeted biologic therapies used to treat psoriasis.
In this exclusive interview, Dr Ronald Vender goes over the highly effective targeted biologic therapies used to treat psoriasis.
In this exclusive interview, Dr...
10/27/2023
Pharmacy Learning Network
Videos
Application of Dupilumab to Pediatric Patients With Atopic Dermatitis
10/27/2023
In this feature video, Dr Abigail Cline discusses current literature to assess reported efficacies, side effects, and risks of using dupilumab to treat atopic dermatitis in pediatric patients.
In this feature video, Dr Abigail Cline discusses current literature to assess reported efficacies, side effects, and risks of using dupilumab to treat atopic dermatitis in pediatric patients.
In this feature video, Dr...
10/27/2023
Pharmacy Learning Network
Videos
Patient Considerations When Prescribing Lecanemab for Alzheimer Disease
10/06/2023
Dr Paul Schulz discusses the newly FDA-approved lecanemab for the treatment of AD.
Dr Paul Schulz discusses the newly FDA-approved lecanemab for the treatment of AD.
Dr Paul Schulz discusses the...
10/06/2023
Pharmacy Learning Network
Headshots of Chris Fausel, PharmD, MHA, BCOP; Erin Hamai Tom, PharmD, APh, MBA, BCACP; and Ryan Nix, PharmD, MMHC
Videos
Specialty Pharmacy Next: Focus on Distribution Processes, Data Utilization, New Drugs, and More
07/18/2023
In this roundtable, cochairs of Specialty Pharmacy Next gather to discuss pertinent topics on the agenda such as white and brown bagging practices and data usage for program growth, as well as who may benefit most from attending the meeting.
In this roundtable, cochairs of Specialty Pharmacy Next gather to discuss pertinent topics on the agenda such as white and brown bagging practices and data usage for program growth, as well as who may benefit most from attending the meeting.
In this roundtable, cochairs of...
07/18/2023
Pharmacy Learning Network
Videos
Leaders in Pharmacy Come Together to Discuss and Debate Oncology-Related Developments
06/28/2021
Chris Fausel, PharmD, Val Adams, PharmD, Kirollos Hanna, PharmD, and Lisa Holle, PharmD, cochairs of Great Debates and Updates Oncology Pharmacy, come together to discuss this new CPE event aimed at educating pharmacists interested in...
Chris Fausel, PharmD, Val Adams, PharmD, Kirollos Hanna, PharmD, and Lisa Holle, PharmD, cochairs of Great Debates and Updates Oncology Pharmacy, come together to discuss this new CPE event aimed at educating pharmacists interested in...
Chris Fausel, PharmD, Val Adams,...
06/28/2021
Pharmacy Learning Network
Expanded FDA Approval Improves Care Access, Rates of Flu Cases
Videos
Expanded FDA Approval Improves Care Access, Rates of Flu Cases
04/19/2021
Gregg Sylvester, MD, MPH, chief medical officer, and David Ross, vice president, commercial operations for North America, both at Seqirus, discuss the recent FDA approval for Flucelvax Quadrivalent, explain what the expanded indication means...
Gregg Sylvester, MD, MPH, chief medical officer, and David Ross, vice president, commercial operations for North America, both at Seqirus, discuss the recent FDA approval for Flucelvax Quadrivalent, explain what the expanded indication means...
Gregg Sylvester, MD, MPH, chief...
04/19/2021
Pharmacy Learning Network
Identifying Drug Diversion Differences in Retail Pharmacies Compared With Health Systems
Videos
Identifying Drug Diversion Differences in Retail Pharmacies Compared With Health Systems
12/28/2020
Tom Knight, founder and CEO, Invistics, identifies drug diversion differences in a hospital or health system versus a retail pharmacy, and explains what retail pharmacies can do to better detect and address drug diversion.
Tom Knight, founder and CEO, Invistics, identifies drug diversion differences in a hospital or health system versus a retail pharmacy, and explains what retail pharmacies can do to better detect and address drug diversion.
Tom Knight, founder and CEO,...
12/28/2020
Pharmacy Learning Network
Identifying Risks of Human Error, Workarounds in Pharmacy
Videos
Identifying Risks of Human Error, Workarounds in Pharmacy
12/22/2020
Matthew Grissinger, RPh, FISMP, FASCP, director of Error Reporting Programs, Institute for Safe Medication Practices, discusses how human error, various at-risk behaviors, as well as workarounds taken by staff members all impact outcomes and...
Matthew Grissinger, RPh, FISMP, FASCP, director of Error Reporting Programs, Institute for Safe Medication Practices, discusses how human error, various at-risk behaviors, as well as workarounds taken by staff members all impact outcomes and...
Matthew Grissinger, RPh, FISMP,...
12/22/2020
Pharmacy Learning Network

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2025 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use